Differential effects of Bacteroides fragilis toxin (BFT)-2 and Clostridium difficile toxin A and B on human colonic mucosa in vitro.

被引：0
作者：
Riegler, M
Sedivy, R
Sogukoglu, T
Sears, C
Castagliuolo, I
Pothoulakis, C
Cosentini, E
Bischof, G
Teleky, B
Feil, W
Hamilton, G
LaMont, JT
Wenzl, E
机构：
[1] UNIV VIENNA, SURG CLIN, VIENNA, AUSTRIA
[2] DANUBE HOSP, VIENNA, AUSTRIA
[3] BETH ISRAEL DEACONESS MED CTR, DIV GASTROENTEROL, BOSTON, MA USA
[4] JOHNS HOPKINS UNIV, DIV INFECT DIS, BALTIMORE, MD USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1072 / A1072
页数：1
相关论文
共 50 条
[21]   Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine [J].
Savidge, TC ;
Pan, WH ;
Newman, P ;
O'Brien, M ;
Anton, PM ;
Pothoulakis, C .
GASTROENTEROLOGY, 2003, 125 (02) :413-420
[22]   Clostridium difficile toxin B is an enterotoxin for human intestine in vivo [J].
Savidge, T ;
Pan, WH ;
Newman, P ;
O'Brien, M ;
Pothoulakis, C .
GASTROENTEROLOGY, 2002, 122 (04) :A76-A76
[23]   Zur Pathogenese der Antibiotikakolitis: Wirkung von Clostridium difficile Toxin A und B auf die humane Kolonschleimhaut in vitroAntibiotic-associated colitis: Effect of clostridium difficile toxins A and B on human colonic mucosa in vitro [J].
M. Riegler ;
R. Sedivy ;
Ch. Pothoulakis ;
B. Teleky ;
G. H. Hamilton ;
J. Zacherl ;
G. Bischof ;
E. Cosentini ;
J. Th. LaMont ;
E. Wenzl .
Acta chirurgica Austriaca, 1997, 29 (2) :95-101
[24]   Oligosaccharides containing sialic acid and n-acetyl glucosamine mediate Clostridium difficile toxin B (TxB) binding and biologic effects in human colonic mucosa [J].
Castagliuolo, I ;
Valenick, L ;
Riegler, M ;
LaMont, JT ;
Pothoulakis, C .
GASTROENTEROLOGY, 1998, 114 (04) :A949-A949
[25]   Early functional effects of Clostridium difficile toxin A on human colonocytes [J].
Branka, JE ;
Vallette, G ;
Jarry, A ;
BouHanna, C ;
Lemarre, P ;
Van, PN ;
Laboisse, CL .
GASTROENTEROLOGY, 1997, 112 (06) :1887-1894
[26]   Effects of adenosine (ADO) on human colonic mucosa in vitro. [J].
Riegler, M ;
Pothoulakis, C ;
Sogukoglu, T ;
Pretenhofer, M ;
Mun, EC ;
Matthews, JB ;
Wlk, M ;
Wenzl, E .
GASTROENTEROLOGY, 2000, 118 (04) :A608-A608
[27]   CYTOKINE RESPONSE BY HUMAN MONOCYTES TO CLOSTRIDIUM-DIFFICILE TOXIN-A AND TOXIN-B [J].
FLEGEL, WA ;
MULLER, F ;
DAUBENER, W ;
FISCHER, HG ;
HADDING, U ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1991, 59 (10) :3659-3666
[28]   EFFECTS OF CLOSTRIDIUM-DIFFICILE TOXIN-A AND TOXIN-B AND THE LETHAL TOXIN OF CLOSTRIDIUM-SORDELLII ON THE RHO-GTPASES [J].
BOQUET, P ;
POPOFF, MR ;
VONEICHELSTREIBER, C ;
GIRY, M .
MICROBIAL ECOLOGY IN HEALTH AND DISEASE, 1995, 8 (04) :191-191
[29]   Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470 [J].
Huelsenbeck, Johannes ;
Dreger, Stefanie ;
Gerhard, Ralf ;
Barth, Holger ;
Just, Ingo ;
Genth, Harald .
INFECTION AND IMMUNITY, 2007, 75 (02) :801-809
[30]   Activation of human mast cells by toxin A and B from clostridium difficile [J].
Neetz, A ;
Just, I ;
Gerhard, R .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 :R132-R132
12345